GlassScriptPhysician profile
Karen A Alvarez
NPI 1689800344
$656.16
in general payments reported to CMS, 2019-2025
15 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.40 · 2021: $25.04 · 2022: $122 · 2023: $43.84 · 2024: $187 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $151.05 | 2025 | Envista Envy Iol |
| Sight Sciences, INC. | $122.36 | 2022 | |
| Abbvie INC. | $101.38 | 2023-2025 | Durysta |
| Topcon Healthcare, INC. | $28.09 | 2023 | |
| Genentech USA, INC. | $27.77 | 2025 | Vabysmo |
| Sandoz INC. | $27.76 | 2024 | Cimerli |
| Harrow Eye, LLC | $26.23 | 2024 | Vevye |
| Apellis Pharmaceuticals, INC. | $26.03 | 2025 | Syfovre |
| Travere Therapeutics, INC. | $25.04 | 2021 | |
| Kedrion Biopharma, INC. | $24.02 | 2024 | Rhogam Ultra-Filtered Plus, Koate, Gammaked |
| Neurotech Pharmaceuticals, INC. | $21.57 | 2025 | |
| Glaukos Corporation | $19.99 | 2024 | Idose |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $18.71 | 2024 | Iyuzeh |
| Alcon Vision LLC | $16.76 | 2024 | Eysuvis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.